Search
for
Sort by
Research 751–780 of 1000+
- Defining and targeting differentiation of non-melanoma skin cancer
- Dormant tumor cells in ret transgenic mouse melanoma model and their interaction with memory T cells
- Prognostic Significance of a Positive Nonsentinel Lymph Node in Cutaneous Melanoma
- Isolated hyperthermic chemotherapy perfusion for limb melanoma is a safe procedure
- Isolated hyperthermic chemotherapy perfusion for limb melanoma is a safe procedure
- Finasteride and dutasteride may reduce melanoma risk
- Cutaneous adverse effects of BRAF inhibitors in metastatic malignant melanoma, a prospective study in 20 patients.
- Impact of the French COVID‐19 pandemic lockdown on newly diagnosed melanoma delay and severity
- Blood MUC-18/MCAM expression in patients with melanoma: a suitable marker of poor outcome
- Clinical Case Notes. Malignant melanoma in eviscerated eyeball
- Bioabsorbable nano-micelle hybridized hydrogel scaffold prevents postoperative melanoma recurrence
- The potential impact of melanosomal pH and metabolism on melanoma
- A case of bullous pemphigoid in a malignant melanoma patient following an increased Th2/Th1 ratio in peripheral blood cells after nivolumab treatment
- Anticancer potential of musa × paradisiaca as cervical carcinoma and malignant melanoma
- Recent Advances in Genetically Engineered Mouse Models of Melanoma: Insights into Tumor Initiation and Oncogenic Signaling Pathways
- Bioorthogonal Catalytic Microneedles Based on a Cytotoxic PEI Matrix for Synergistic Melanoma Therapy
- Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
- A bibliometric study of the top 100 most cited articles on melanoma: insights into research trends and characteristics
- Differential effects of dehydroepiandrosterone (DHEA) between mouse and human melanoma cell lines
- B‐ RAF , naevi and melanoma: a complex relationship
- Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma
- A Prospective Study of Cutaneous Adverse Events Induced by Low-Dose Alpha-Interferon Treatment for Malignant Melanoma
- Hair and nail adverse events during treatment with targeted therapies for metastatic melanoma
- Effect of adipose-derived stem cell-conditioned medium on the proliferation and migration of B16 melanoma cells
- The risk of dermatological toxicities of combined BRAF and MEK inhibition versus BRAF inhibition alone in melanoma patients: a systematic review and meta-analysis
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- 42197 The Impact of the COVID-19 Pandemic on Sun Habits of Patients with Melanoma: A Cross- sectional Study
- Morphologic comparison of cultured human epidermis melanocytes,amelanotic melanocytes from hair follicles and mouse melanoma cells observed by atomic force microscope
- Characteristics and survival outcomes of untreated, resectable stage I–III melanoma patients in Serbia
- Multicentric parallel phase II trial of the polo-like kinase 1 inhibitor BI 2536 in patients with advanced head and neck cancer, breast cancer, ovarian cancer, soft tissue sarcoma and melanoma. The first protocol of the European Organization for Research and Treatment of Cancer (EORTC) Network Of Core Institutes (NOCI)